Literature DB >> 33526449

A Leucine-Rich Repeat Protein Provides a SHOC2 the RAS Circuit: a Structure-Function Perspective.

Jason J Kwon1,2,3, William C Hahn4,2,3,5.   

Abstract

SHOC2 is a prototypical leucine-rich repeat protein that promotes downstream receptor tyrosine kinase (RTK)/RAS signaling and plays important roles in several cellular and developmental processes. Gain-of-function germ line mutations of SHOC2 drive the RASopathy Noonan-like syndrome, and SHOC2 mediates adaptive resistance to mitogen-activated protein kinase (MAPK) inhibitors. Similar to many scaffolding proteins, SHOC2 facilitates signal transduction by enabling proximal protein interactions and regulating the subcellular localization of its binding partners. Here, we review the structural features of SHOC2 that mediate its known functions, discuss these elements in the context of various binding partners and signaling pathways, and highlight areas of SHOC2 biology where a consensus view has not yet emerged.
Copyright © 2021 American Society for Microbiology.

Entities:  

Keywords:  MAPK signaling; Noonan syndrome; PP1C; RAF; RAS; SHOC2; cancer; leucine-rich repeat; receptor tyrosine kinase

Mesh:

Substances:

Year:  2021        PMID: 33526449     DOI: 10.1128/MCB.00627-20

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  4 in total

1.  Nuclear p120 catenin is a component of the perichromosomal layer and coordinates sister chromatid segregation during mitosis in lung cancer cells.

Authors:  Shu-Er Chow; Yaa-Jyuhn J Meir; Jhy-Ming Li; Ping-Chih Hsu; Cheng-Ta Yang
Journal:  Cell Death Dis       Date:  2022-06-04       Impact factor: 9.685

2.  Structure of the MRAS-SHOC2-PP1C phosphatase complex.

Authors:  Zachary J Hauseman; Michelle Fodor; Anxhela Dhembi; Jessica Viscomi; David Egli; Melusine Bleu; Stephanie Katz; Eunyoung Park; Dong Man Jang; Kathryn A Porter; Fabian Meili; Hongqiu Guo; Grainne Kerr; Sandra Mollé; Camilo Velez-Vega; Kim S Beyer; Giorgio G Galli; Saveur-Michel Maira; Travis Stams; Kirk Clark; Michael J Eck; Luca Tordella; Claudio R Thoma; Daniel A King
Journal:  Nature       Date:  2022-07-13       Impact factor: 69.504

3.  Systematic profiling of conditional degron tag technologies for target validation studies.

Authors:  William R Sellers; Alessandra Ianari; Daniel P Bondeson; Zachary Mullin-Bernstein; Sydney Oliver; Thomas A Skipper; Thomas C Atack; Nolan Bick; Meilani Ching; Andrew A Guirguis; Jason Kwon; Carly Langan; Dylan Millson; Brenton R Paolella; Kevin Tran; Sarah J Wie; Francisca Vazquez; Zuzana Tothova; Todd R Golub
Journal:  Nat Commun       Date:  2022-09-20       Impact factor: 17.694

4.  Expanding the molecular spectrum of pathogenic SHOC2 variants underlying Mazzanti syndrome.

Authors:  Marialetizia Motta; Maja Solman; Adeline A Bonnard; Alma Kuechler; Francesca Pantaleoni; Manuela Priolo; Balasubramanian Chandramouli; Simona Coppola; Simone Pizzi; Erika Zara; Marco Ferilli; Hülya Kayserili; Roberta Onesimo; Chiara Leoni; Julia Brinkmann; Yoann Vial; Susanne B Kamphausen; Cécile Thomas-Teinturier; Anne Guimier; Viviana Cordeddu; Laura Mazzanti; Giuseppe Zampino; Giovanni Chillemi; Martin Zenker; Hélène Cavé; Jeroen den Hertog; Marco Tartaglia
Journal:  Hum Mol Genet       Date:  2022-08-23       Impact factor: 5.121

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.